SEARCH

SEARCH BY CITATION

References

  • Aucoin JS, Jiang P, Aznavour N, Tong XK, Buttini M, Descarries L & Hamel E (2005). Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease. Neurosci 132, 7386.
  • Benarroch E (2007). Neurovascular unit dysfunction: a vascular component of Alzheimer's disease. Neurology 68, 17301732.
  • Buée L, Hof PR, Bouras C, Delacourte A, Perl DP, Morrison JH & Fillit HM (1994). Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol 87, 469480.
  • De La Torre JC (2005). Is Alzheimer's disease preceded by neurodegeneration or cerebral hypoperfusion? Ann Neurol 57, 783784.
  • Gaertner RF, Wyss-Coray T, Von Euw D, Lesne S, Vivien D & Lacombe P (2005). Reduced brain tissue perfusion in TGF-β1 transgenic mice showing Alzheimer's disease-like cerebrovascular abnormalities. Neurobiol Dis 19, 3846.
  • Galea E, Feinstein DL & Lacombe P (2006). Pioglitazone does not increase cerebral glucose utilisation in a murine model of Alzheimer's disease and decreases it in wild-type mice. Diabetologia 49, 21532161.
  • Grammas P & Ovase R (2002). Cerebrovascular transforming growth factor-β contributes to inflammation in the Alzheimer's disease brain. Am J Pathol 160, 15831587.
  • Hamel E (2004). Cholinergic modulation of the cortical microvascular bed. Progr Brain Res 145, 171178.
  • Iadecola C (2004). Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Neurosci Rev 5, 347360.
  • Iadecola C, Zhang F, Niwa K, Eckman C, Turner SK, Fischer E, Younkin S, Borchelt DR, Hsiao KK & Carlson GA (1999). SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci 2, 157161.
  • Kalaria RN (1997). Cerebrovascular degeneration is related to amyloid-β protein deposition in Alzheimer's disease. Ann NY Acad Sci 826, 263271.
  • Luedecking EK, DeKosky ST, Mehdi H, Ganguli M & Kamboh MI (2000). Analysis of genetic polymorphisms in the transforming growth factor-β1 gene and the risk of Alzheimer's disease. Hum Genet 106, 565569.
  • Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K & McConlogue L (2000). High-level neuronal expression of Aβ1–42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20, 40504058.
  • Nicolakakis N, Aboulkassim T & Hamel E (2006). Reversal of fully-developed cerebrovascular deficits in aged human amyloid precusor protein (hAPP) transgenic mice. 36th Annual Meeting of the Society for Neuroscience, Abstract no. 117.4, Atlanta , GA , USA .
  • Nicolakakis N, Tong XK & Hamel E (2005). Reversal of fully developed cerebrovascular dysfunctions in two transgenic mouse models of Alzheimer's disease. Brain '05, Abstract no. 169, Amsterdam , The Netherlands .
  • Niwa K, Kazama K, Younkin SG, Carlson GA & Iadecola C (2002a). Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein. Neurobiol Dis 9, 6168.
  • Niwa K, Kazama K, Younkin L, Younkin SG, Carlson GA & Iadecola C (2002b). Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am J Physiol Heart Circ Physiol 283, H315H323.
  • Palop JJ, Jones B, Kekonius L, Chin J, Yu GQ, Raber J, Masliah E & Mucke L (2003). Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Proc Natl Acad Sci U S A 100, 95729577.
  • Paris D, Town T, Mori T, Parker TA, Humphrey J & Mullan M (2000). Soluble β-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway. Neurobiol Aging 21, 183197.
  • Park L, Anrather J, Forster C, Kazama K, Carlson GA & Iadecola C (2004). Aβ-induced vascular oxidative stress and attenuation of functional hyperemia in mouse somatosensory cortex. J Cerebr Blood Flow Metab 24, 334342.
  • Park L, Anrather J, Zhou P, Frys K, Pitstick R, Younkin S, Carlson GA & Iadecola C (2005). NADPH oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid β peptide. J Neurosci 25, 17691777.
  • Shi J, Perry G, Smith MA & Friedland RP (2000). Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease. Neurobiol Aging 21, 357361.
  • Tong XK & Hamel E (1999). Regional cholinergic denervation of cortical microvessels and nitric oxide synthase-containing neurons in Alzheimer's disease. Neurosci 92, 163175.
  • Tong XK & Hamel E (2007). Transforming growth factor-β1 impairs endothelin-1-mediated contraction of brain vessels via induction of mitogen-activated protein kinase phosphatase-1 and inhibition of p38 MAP kinase. Mol Pharmacol, in press.
  • Tong XK, Nicolakakis N, Kocharian A & Hamel E (2005). Vascular remodeling versus amyloid β-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease. J Neurosci 25, 1116511174.
  • Vinters HV, Secor DL, Read SL, Frazee JG, Tomiyasu U, Stanley TM, Ferreiro JA & Akers MA (1994). Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: an immunohistochemical and ultrastructural study. Ultrastruct Pathol 18, 333348.
  • Wyss-Coray T, Lin C, Sanan DA, Mucke L & Masliah E (2000). Chronic overproduction of transforming growth factor-β1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. Am J Pathol 156, 139150.
  • Yamada Y, Fujisawa M, Ando F, Niino NTM & Shimokata H (2002). Association of a polymorphism of the transforming growth factor-β1 gene with blood pressure in Japanese individuals. J Hum Genet 47, 243248.
  • Zarow C, Barron E, Chui HC & Perlmutter LS (1997). Vascular basement membrane pathology and Alzheimer's disease. Ann NY Acad Sci 826, 147160.
  • Zlokovic BV (2005). Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci 28, 202208.